Molecular Pathology of
Hepatocellular Carcinoma
Hepatocellular Carcinoma
|
Molecular Pathology of Hepatocellular Carcinoma |
| Home | • | About | • | Our Team | • | Expert Opinion | • | CuraBase Workspace | • | Contact |
|
| Region | Incidence Overall | Incidence Males | Incidence Females | Deaths Overall | Deaths Males | Deaths Females |
|---|---|---|---|---|---|---|
| USA | 24120 | 17430 | 6690 | 18910 | 12720 | 6190 |
| Affected Protein | Pathway | Sub-Type | Ethnicity | Stage | Frequency (%) | Gene Amplification | Activating Mutation | Inactivating Mutation | Deletion | Promoter Hypermethylation | Comment | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pi3-kinase | PI3-Kinase Signaling |
2% |
| See Clinical Trials in in the TTC Database |
| CANCER.GOV PDQ® - Standard Treatments for Hepatocellular Carcinoma |